SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Company Response from Evolent Health, Inc. (EVH) (CIK 0001628908) (EVH) — Jun 1, 2015

Evolent Health, Inc. (EVH) (CIK 0001628908)
Date: June 1, 2015 · CIK: 0001628908 · Accession: 0001193125-15-209600

AI Filing Summary & Sentiment

File numbers found in text: 333-203852

Date
May 19, 2015
Author
William V. Fogg
Form
CORRESP
Company
Evolent Health, Inc. (EVH) (CIK 0001628908)

Letter

May 19, 2015 Evolent Health, Inc. Registration Statement on Form S-1 File No. 333-203852

Dear Ms. Gowetski:

On May 18, 2015, Evolent Health, Inc. filed with the Securities and Exchange Commission, via EDGAR, Amendment No. 1 (“Amendment No. 1”) to its Registration Statement on Form S-1 (File No. 333-203852) (the “Registration Statement”).

Four copies of certain changed pages that are marked to show certain proposed changes from Amendment No. 1 to the Registration Statement are enclosed for your review.

Please contact me at (212) 474-1131 with any questions or comments you may have regarding the Registration Statement.

Very truly yours,
William V. Fogg

Show Raw Text
CORRESP
1
filename1.htm

SEC Cover Letter

 May 19, 2015

Evolent Health, Inc.

Registration Statement on Form S-1

File No. 333-203852

 Dear Ms. Gowetski:

 On May 18, 2015, Evolent Health, Inc. filed with the Securities and Exchange Commission, via EDGAR, Amendment No. 1 (“Amendment
No. 1”) to its Registration Statement on Form S-1 (File No. 333-203852) (the “Registration Statement”).

 Four
copies of certain changed pages that are marked to show certain proposed changes from Amendment No. 1 to the Registration Statement are enclosed for your review.

 Please contact me at (212) 474-1131 with any questions or comments you may have regarding the
Registration Statement.

 Very truly yours,

William V. Fogg

 Jennifer Gowetski

Senior Counsel

 U.S. Securities
and Exchange Commission

 Division of Corporation Finance

100 F Street, N.E.

 Washington,
D.C. 20549

 Encls.

 Copy w/encls. to:

Rahul Patel

 Howard Efron

Robert Telewicz

 U.S. Securities and Exchange
Commission

 Division of Corporation Finance

100 F Street, N.E.

 Washington,
D.C. 20549

 Jonathan Weinberg

 General
Counsel

 Evolent Health, Inc.

800 N. Glebe Road, Suite 500

Arlington, Virginia 22203

 BY EDGAR; FED EX

 2